key: cord-0285365-rod10mmx authors: Martin, E. T.; Lauring, A. S.; Montgomery, J. P.; Valesano, A. L.; Eisenberg, M. C.; Sheen, D.; Nord, J.; Ernst, R. D.; Mortenson, L. Y.; Valdez, R.; Niknafs, Y.; Conway, D.; Rifat, S. F.; Bagdasarian, N.; Lyon-Callo, S.; Collins, J.; Blakenship, H.; Soehnlen, M.; Marquez, J. title: Containment of a multi-index B.1.1.7 outbreak on a university campus through a genomically-informed public health response date: 2022-01-05 journal: nan DOI: 10.1101/2022.01.04.22268758 sha: 154c727bfb682b8d540f9f1dcb09598dfe3b13ab doc_id: 285365 cord_uid: rod10mmx The first cluster of SARS-CoV-2 cases with lineage B.1.1.7 in the state of Michigan was identified through intensive university-led surveillance sampling and targeted sequencing. A collaborative investigation and response was conducted by the local and state health departments, and the campus and athletic medicine COVID-19 response teams, using S-gene target failure screening and rapid genomic sequencing to inform containment strategies. A total of 50 cases of B.1.1.7-lineage SARS-CoV-2 were identified in this outbreak, which was due to three coincident introductions of B.1.1.7-lineage SARS-CoV-2, all of which were genetically distinct from lineages which later circulated in the broader community. This investigation demonstrates the successful implementation of a genomically-informed outbreak response which can be extended to university campuses and other settings at high risk for rapid emergence of new variants. The continued emergence of SARS-CoV-2 variants has brought much attention to the need for genomic surveillance at both global and local scales. Despite rapid advances in the scale and availability of SARS-CoV-2 sequencing, challenges remain in determining how best to make sequencing data actionable at an individual level as part of the case investigation and contact tracing process. The emergence of the B. Students have larger networks of contacts compared to the non-university community, and congregate living is more common, whether in residence halls or in large houses. At the start of each semester or during academic breaks (4, 5) , the frequency of travel to the local campus area from both domestic and international locations facilitates new introductions of SARS-CoV-2 viruses from other regions. Many universities have implemented asymptomatic testing programs at various scales. These programs offer a level of All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted January 5, 2022. ; https://doi.org/10.1101/2022.01.04.22268758 doi: medRxiv preprint 4 testing that extends beyond what is available to the general public. This increased testing enables earlier identification of introductions of virus and, when coupled with genomic surveillance, earlier identification of variants of concern. While important for informing initiatives to reduce transmission on campus, these efforts also give a more detailed picture of virus introduction and spread than what is possible to observe outside of a university campus. On January 16, 2021, the first cluster of SARS-CoV-2 cases with lineage B.1. 1.7 (Alpha) in the state of Michigan was identified through intensive university-led surveillance sampling followed by targeted sequencing by the Michigan Department of Health and Human Services (MDHHS) Bureau of Laboratories. A collaborative investigation and response was conducted jointly by the local and state health departments, and the campus and athletic medicine COVID-19 response teams. This investigation paired genomic sequencing with enhanced case investigation and contact tracing to identify and contain the outbreak. Through coupling data from a university student testing program with rapid turnaround genomic surveillance, we were able to trace the emergence, spread and containment of the B.1.1.7 variant in a university campus community. Here we describe the genomic epidemiology of the variant as well as the testing and mitigation efforts that combined to ensure early identification and rapid containment of the outbreak. The initial B.1.1.7 isolate was identified in an individual who was participating in an athleticswide testing program for all student athletes; this included return to campus reverse transcription-polymerase chain reaction (RT-PCR) testing, daily conference-mandated rapid All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted January 5, 2022. ; https://doi.org/10.1101/2022.01.04.22268758 doi: medRxiv preprint antigen testing with RT-PCR confirmation of positive results for in-season athletes, and once to thrice weekly (depending on sport) RT-PCR for out-of-season athletes. This initial specimen was sent to MDHHS for whole genome sequencing based on recent travel to the United Kingdom. An enhanced testing and genomic sequencing protocol was initiated to identify the lineage of all university-associated cases upon identification of the first B.1.1.7 case. All students were required to complete a daily app-based symptom screen, and symptomatic students were at Michigan Medicine were also processed for sequencing. Residual nasopharyngeal and saliva All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted January 5, 2022. ; https://doi.org/10.1101/2022.01.04.22268758 doi: medRxiv preprint 6 specimens from symptomatic and asymptomatic individuals who tested positive for SARS-CoV-2 by RT-PCR were obtained from the Michigan Medicine Clinical Microbiology Laboratory, University Health Services, and LynxDx (Ann Arbor, MI). Specimens from individuals living in congregate settings (residence halls, or fraternity, sorority or cooperative houses), from individuals with recent travel, or from student athletes were prioritized for sequencing on the Nanopore platform, which allowed for more rapid identification of B.1.1.7 cases than with the Illumina platform (Supplementary Figure 1 ). Specimens were processed using the Artic Network v3 primer pools and protocol(6,7). To generate a phylogenetic tree, we aligned consensus genomes with MUSCLE 3.8.31 and masked positions that are known to commonly exhibit homoplasies or sequencing errors(8). We generated a maximum likelihood phylogeny with IQ-TREE, using a GTR model and 1000 ultrafast bootstrap replicates (9, 10) . Evolutionary lineages (Pango lineages) were assigned with PANGOLIN (11) . Pangolin lineage assignment with >90% genome coverage was considered confirmatory laboratory evidence of B.1.1.7. Sequencing results with less than 90% coverage but with greater than 50% of hallmark lineage mutations detected and over 50% of genome coverage were considered presumptive laboratory evidence of B.1.1.7. Individuals with confirmatory sequence-based laboratory evidence of B.1.1.7 were classified as confirmed B.1.1.7 cases for the purposes of the outbreak investigation. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted January 5, 2022. Twenty-six first-level contacts (close contacts and team members) were identified. Ten of these first-level contacts subsequently became positive for SARS-CoV-2. An additional 4 cases were identified among 38 contacts of contacts (i.e. second-level contacts). In total, 15 cases with an epidemiologic linkage to cluster A were identified over 18 days. During the investigation of the initial cluster, seven of the 10 initial close contacts with SARS-CoV-2 were confirmed as lineage B.1.1.7, and one of the 4 second-level contacts with SARS-CoV-2 was confirmed as B.1.1.7 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted January 5, 2022. C5192T and C27513T were unique to genomes in cluster C. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted January 5, 2022. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted January 5, 2022. The worldwide emergence of a succession of variants of concern, and the resulting impacts on disease incidence, are a stark demonstration of the critical importance of continued All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted January 5, 2022. ; https://doi.org/10.1101/2022.01.04.22268758 doi: medRxiv preprint genomic tracking throughout the next phase of the COVID-19 pandemic. The outbreak described here provided a unique opportunity to directly observe lineage-specific emergence and spread and to initiate genomically-informed public health response at the local level. The processes used here are particularly informative as universities and other communities plan responses to Omicron, which also can be detected through an SGTF pattern, enabling efficient use of RT-PCR screening followed by targeted sequencing. Here we report the early identification of three initial introductions of an emerging lineage into a college campus, a high-risk population for SARS-CoV-2 spread(5,15,16) and emergence of travel-associated variants(4). The investigation benefited from available infrastructure for widescale asymptomatic testing and for genomic surveillance. This infrastructure substantially increased the speed with which the first B.1.1.7 case was identified. By virtue of extensive sequencing and weekly testing of the campus population in January and February 2021 (over 1,300 specimens sequenced in January and February), we were able to document three introduction events, all resulting from travel. There are a number of lessons learned from this experience that can directly inform the response of the international community to additional VOCs. We used just-in-time sequencing to deploy a genomically-informed mitigation strategy that included enhanced case investigation and contact tracing methods and frequent testing in the specific communities with exposure to B.1.1.7. We paired this strategy with initial testing with a RT-PCR assay to distinguish non-B.1.1.7 cases, enabling us to prioritize sequencing resources accordingly. These methods were ultimately successful in preventing larger community transmission resulting from the first two transmission events, thus delaying widespread predominance of B.1.1.7 for multiple weeks. Importantly, genomic data made it clear when the mitigation measures were successful for specific B.1.1.7 clusters. Clusters All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted January 5, 2022. ; https://doi.org/10.1101/2022.01.04.22268758 doi: medRxiv preprint ceased to have genomic descendants once transmission was controlled, which allowed measures targeted towards specific risk cohorts to be ended. The investigation described here has shown clearly that the emergence of B.1.1.7 into the community was not due to a single introduction. This is most apparent on this smaller scale, where individual clusters can be characterized, and this is consistent with patterns of emergence that are observed at a larger level, through counties, states and communities. Simplistic epidemiologic curves of cases give the impression that a single initiating infection led to an exponential rise. However, the addition of genomic data, such as that presented here, makes it clear that introductions are complex and multifaceted, with what appeared to be a single outbreak due to 3 introductions. Genomic data also demonstrated little genetic similarity between these initial clusters and viruses that ultimately emerged in the broader community, a pattern noted previously in our area (17) . While a number of both B.1.1.7 and non-B.1.1.7 cases during this time period were first identified through asymptomatic surveillance, it is notable that almost all cases eventually reported symptoms at some point during the case investigation and follow-up process, with 95% of B.1.1.7 cases reporting symptoms. This finding is in contrast to other evaluations that have reported the fraction of completely asymptomatic cases to be above 25% (18) (19) (20) . This difference could be explained by population differences, or differences in intensity of follow-up for symptoms in the context of an investigation of an emerging variant. Our data underscore the fact that the asymptomatic proportion of a COVID-19 outbreak may be overestimated, and thus the clinical impact underestimated, when subsequent development of symptoms is not ascertained in the days following testing (21, 22) . All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted January 5, 2022. ; https://doi.org/10.1101/2022.01.04.22268758 doi: medRxiv preprint As SARS-CoV-2 variants continue to emerge, these results demonstrate that highresolution testing and sequencing, when coupled with targeted public health mitigation measures (increased frequency of testing, expanded case investigation and contact tracing interviews, and enhanced quarantine practices), can delay larger dissemination of a more transmissible strain in a campus setting. This strategy can inform efforts to control future SARS-CoV-2 variant emergence as colleges and communities target genomic surveillance resources into the next phase of the pandemic. Residual transport media or saliva was centrifuged at 1200 x g. and aliquoted. For (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Reaction products for a given sample were pooled together in equal volumes. Pooled PCR product was purified with 1X volume of AMPure beads (Beckman-Coulter). Oxford Nanopore library preparation and sequencing After multiplex PCR amplification, libraries were prepared for sequencing with the Oxford Nanopore Technologies MinION using the ARTIC Network version 3 protocol (6,7). Samples were prepared in batches of 24 with one-pot native barcoding. Pooled PCR products were diluted in nuclease-free water with a dilution factor of 10. Amplicon ends were prepared for ligation with the NEBNext Ultra II End Repair/dA-Tailing Module (NEB). Unique barcodes (Oxford Nanopore Native Barcoding Expansion kits) were ligated per sample with the NEB Blunt/TA Ligase Master Mix. After barcoding, reactions were pooled together in equal volumes All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted January 5, 2022. Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted Genomic reconstruction of the SARS-CoV-2 epidemic in England Multiple Variants of SARS-CoV-2 in a University Outbreak After Spring Break Multiple COVID-19 Clusters on a University Campus -North Carolina Early introductions and transmission of SARS-CoV-2 variant B.1.1.7 in the United States nCoV-2019 sequencing protocol v3 (LoCost) Masking strategies for SARS-CoV-2 alignments -SARS-CoV-2 coronavirus / Software and Tools No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted MUSCLE: multiple sequence alignment with high accuracy and high throughput IQ-TREE: a fast and effective stochastic algorithm for estimating maximum-likelihood phylogenies A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology -Emerging Infectious Diseases journal -CDC A New Framework and Software to Estimate Time-Varying Reproduction Numbers During Epidemics Considerations for Reopening Institutions of Higher Education in the COVID-19 No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted Response to a COVID-19 Outbreak on a University Campus -Indiana SARS-CoV-2 Genomic Surveillance Reveals Little Spread From a Large University Campus to the Surrounding Community. Open Forum Infect Dis COVID-19: PCR screening of asymptomatic health-care workers at London hospital. The Lancet Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19) The Proportion of SARS-CoV-2 Infections That Are Asymptomatic CoV-2 infection: A systematic review and meta-analysis University COVID response funds. All rights reserved. No reuse allowed without permission.(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.The copyright holder for this preprint this version posted January 5, 2022. All rights reserved. No reuse allowed without permission.(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.The copyright holder for this preprint this version posted January 5, 2022. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.The copyright holder for this preprint this version posted January 5, 2022. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.The copyright holder for this preprint this version posted January 5, 2022. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.The copyright holder for this preprint this version posted January 5, 2022. All rights reserved. No reuse allowed without permission.(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.The copyright holder for this preprint this version posted January 5, 2022. ; https://doi.org/10.1101/2022.01.04.22268758 doi: medRxiv preprint